|
|
|
|
A Look at the Newest Generation of Antidepressants
|
According to the Journal of the American Medical Association, in 1987 1.7 million Americans, or 0.7 percent of the population, were being treated for depression. By 1997, this number had more than tripled to 6.2 million people, or 2.3 percent of the population. Patients treated for depression were almost 5 times as likely to receive an antidepressant in 1997 than 1987. |
![]() ![]() ![]() |
In 1987, Prozac
arrived on the commercial market.
|
![]() ![]() ![]() |
The "serotonin revolution" of the late 20th century refers to the explosion of mood and behavior altering drugs known as SSRIs (Selective Serotonin Reuptake Inhibitors). This new class of drugs includes Prozac, Paxil, Zoloft, often called the "big three" and others such as Luvox and Celexa. As their popularity has soared, SSRIs have attained celebrity-like status and have become the subject of much commentary and debate.
Popularity
![]() |
Antidepressants were prescribed to more than half of the individuals who received treatment for depression in 1997. |
![]() |
In 2000, Prozac manufacturer Eli Lilly and Co. claimed that over 35 million people worldwide have taken Prozac. |
![]() |
Today, almost one in ten Americans has used an antidepressant drug. Chances are good that you know someone who is taking or has taken an antidepressant drug. |
Read on to learn more: